Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers

WALGREEN CO

NPI: 1750397493 · GILBERT, AZ 85233 · Durable Medical Equipment & Medical Supplies · NPI assigned 08/01/2006

Billing Flags · Automated signals — not evidence of fraud
Entity Proliferation

Authorized official PONCE, JENNIFER controls 20+ related entities in our dataset. Read more

$71K
Total Medicaid Paid
1,463
Total Claims
666
Beneficiaries
7
Codes Billed
2019-05
First Month
2022-02
Last Month

Provider Details

Authorized OfficialPONCE, JENNIFER (MANAGER)
Parent OrganizationWALGREENS BOOTS ALLIANCE INC
NPI Enumeration Date08/01/2006

Related Entities

Other providers sharing the same authorized official: PONCE, JENNIFER

ProviderCityStateTotal Paid
CYSTIC FIBROSIS SERVICES LLC FRISCO TX $205K
WALGREEN CO SHELTON CT $31K
WALGREEN CO WHITEVILLE NC $26K
WALGREEN CO HAMDEN CT $22K
WALGREEN CO LAKEWOOD CO $20K
WALGREEN CO DE PERE WI $17K
WALGREEN CO KINSTON NC $16K
DUANE READE NEW YORK NY $7K
WALGREEN CO VIROQUA WI $6K
WALGREEN CO GUILDERLAND NY $6K
WALGREEN CO APEX NC $5K
WALGREEN CO WILMINGTON NC $4K
WALGREEN CO GEORGETOWN SC $720.00
WALGREEN CO BRYANT AR $290.52
WALGREEN CO HESPERIA CA $281.52
WALGREEN CO SHORELINE WA $240.00
WALGREEN CO COVINGTON LA $74.79
WALGREEN CO GLENVIEW IL $2.20
WALGREEN CO POUGHKEEPSIE NY $0.00
WALGREEN CO MITCHELL SD $0.00

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2019 278 $15K
2020 214 $9K
2021 723 $34K
2022 248 $13K

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 616 271 $23K
99213 Office or other outpatient visit for the evaluation and management of an established patient, low complexity 416 191 $21K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed 313 142 $19K
99214 Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 47 26 $3K
90834 Psychotherapy, 45 minutes with patient 35 12 $3K
G0481 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed 20 12 $2K
80305 16 12 $142.72